| Jennine Marie Varhola, DO | |
|
5050 Ne Hoyt St Ste 362, Portland, OR 97213-2983 | |
| (503) 239-6800 | |
| (503) 239-0006 |
| Full Name | Jennine Marie Varhola |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 5050 Ne Hoyt St Ste 362, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164508768 | NPI | - | NPPES |
| 102194 | Medicaid | OR | |
| 2020577 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO150801 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
British scientists say a male contraceptive pill could be on the market within five years.
Surgical patients appear to recover faster and more reliably than patients treated with functional bracing.
Edifecs, Inc., a leading provider of healthcare software solutions specializing in Healthcare Channel Modernization for HIPAA 5010 and ICD-10, announced today that HealthPlus of Michigan has selected Edifecs solutions to accelerate their efforts to meet the upcoming HIPAA 5010 compliance mandate. HealthPlus, a nonprofit health benefits company serving more than 200,000 people throughout the state of Michigan, will use Edifecs SpecBuilder and XEngine products for mapping and translation of inbound and outbound HIPAA 5010 transactions.
The joy of a juicy hamburger could make a comeback thanks a new discovery by scientists from the University of Kentucky. In a new research report in the December 2010 print issue of The FASEB Journal, scientists found that a protein our body uses to break up blood clots speeds up the progress of prion diseases. This substance, called plasminogen, is a new drug target for prion diseases in both humans and animals.
› Verified 9 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
British scientists say a male contraceptive pill could be on the market within five years.
Surgical patients appear to recover faster and more reliably than patients treated with functional bracing.
Edifecs, Inc., a leading provider of healthcare software solutions specializing in Healthcare Channel Modernization for HIPAA 5010 and ICD-10, announced today that HealthPlus of Michigan has selected Edifecs solutions to accelerate their efforts to meet the upcoming HIPAA 5010 compliance mandate. HealthPlus, a nonprofit health benefits company serving more than 200,000 people throughout the state of Michigan, will use Edifecs SpecBuilder and XEngine products for mapping and translation of inbound and outbound HIPAA 5010 transactions.
The joy of a juicy hamburger could make a comeback thanks a new discovery by scientists from the University of Kentucky. In a new research report in the December 2010 print issue of The FASEB Journal, scientists found that a protein our body uses to break up blood clots speeds up the progress of prion diseases. This substance, called plasminogen, is a new drug target for prion diseases in both humans and animals.
› Verified 9 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
British scientists say a male contraceptive pill could be on the market within five years.
Surgical patients appear to recover faster and more reliably than patients treated with functional bracing.
Edifecs, Inc., a leading provider of healthcare software solutions specializing in Healthcare Channel Modernization for HIPAA 5010 and ICD-10, announced today that HealthPlus of Michigan has selected Edifecs solutions to accelerate their efforts to meet the upcoming HIPAA 5010 compliance mandate. HealthPlus, a nonprofit health benefits company serving more than 200,000 people throughout the state of Michigan, will use Edifecs SpecBuilder and XEngine products for mapping and translation of inbound and outbound HIPAA 5010 transactions.
The joy of a juicy hamburger could make a comeback thanks a new discovery by scientists from the University of Kentucky. In a new research report in the December 2010 print issue of The FASEB Journal, scientists found that a protein our body uses to break up blood clots speeds up the progress of prion diseases. This substance, called plasminogen, is a new drug target for prion diseases in both humans and animals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennine Marie Varhola, DO 847 Ne 19th Ave, Suite 300, Portland, OR 97232-2684 Ph: (503) 963-2801 | Jennine Marie Varhola, DO 5050 Ne Hoyt St Ste 362, Portland, OR 97213-2983 Ph: (503) 239-6800 |
News Archive
British scientists say a male contraceptive pill could be on the market within five years.
Surgical patients appear to recover faster and more reliably than patients treated with functional bracing.
Edifecs, Inc., a leading provider of healthcare software solutions specializing in Healthcare Channel Modernization for HIPAA 5010 and ICD-10, announced today that HealthPlus of Michigan has selected Edifecs solutions to accelerate their efforts to meet the upcoming HIPAA 5010 compliance mandate. HealthPlus, a nonprofit health benefits company serving more than 200,000 people throughout the state of Michigan, will use Edifecs SpecBuilder and XEngine products for mapping and translation of inbound and outbound HIPAA 5010 transactions.
The joy of a juicy hamburger could make a comeback thanks a new discovery by scientists from the University of Kentucky. In a new research report in the December 2010 print issue of The FASEB Journal, scientists found that a protein our body uses to break up blood clots speeds up the progress of prion diseases. This substance, called plasminogen, is a new drug target for prion diseases in both humans and animals.
› Verified 9 days ago
Dr. Rachel L Gutfreund, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10101 Se Main St Ste 3001, Portland, OR 97216 Phone: 503-261-4423 Fax: 503-261-4424 | |
John Gilbert Buckmaster, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4200 | |
Darlene J Dodson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9205 Sw Barnes Rd Fl 3, Portland, OR 97225 Phone: 503-216-3388 | |
Antonio E Frias, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-418-4200 Fax: 503-494-4473 | |
Sig-linda Jacobson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5006 Sw Martha St, Portland, OR 97221 Phone: 503-806-7854 | |
Laila Raad Sillay, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9555 Sw Barnes Rd Ste 360, Portland, OR 97225 Phone: 503-445-0590 | |
Edward Paul Kirk, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4500 |